approval · primary record
OLANZAPINE PAMOATE
FDA · NDA · 2026-05-07
| Agency | FDA |
|---|---|
| Submission type | NDA |
| Action date | 2026-05-07 |
| Brand | ZYPREXA RELPREVV |
| Sponsor | CHEPLAPHARM |
| Route | INTRAMUSCULAR |
Provenance
- Source: openFDA Drugs@FDA
- Fetched at: 2026-10-28T02:35:37.754Z
- Licence class: public-domain
- Verdict: primary-source
- Entity id: FDA:OLANZAPINE PAMOATE:2026-05-07
This record is rendered from the AEaH spine. If the source is unreachable the page is not generated.